• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Emerging Infectious Disease Market Trends, 2022

$0.00 – $10,000.00

Clear
SKU: 22-032 Categories: Diagnostics Market Research, Infectious Disease Tags: airborne pathogens, CCHF, Chagas Testing Market, Chikungunya Testing Market, Dengue Fever Testing Market, disease, Ebola Testing Market, Emerging Infectious Diseases Market, fever, Lassa Fever, Lyme Disease Testing Market, Malaria Testing Market, monkey pox, mosquito-borne, Nipah, Rift Valley Fever, tick-borne, tuberculosis, vectors, virus, West Nile Virus, Zika Testing Market Pages: 96
  • Description
  • Table of Contents
  • Latest reports

Description

The search for the next large-scale emerging disease was on before the COVID-19 pandemic.  Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat.  The search is constant, and is by no means limited to respiratory epidemics.  As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats.  This necessitates the development of tests at laboratories.  For business planners, it’s worthwhile to have a resource describing the possible next pathogens of serious concern.

Emerging Infectious Disease Market Trends, 2022 is designed to provide a substantial look at Emerging Infectious Disease Trends with market numbers for significant categories.

This report includes:

  • The Market in 2022 and the Forecast for 2027 for Diagnostics for Emerging Infections
  • Discussion of Scores of Emerging Infectious Diseases of Various Categories Including:
    • Viral
    • Bacterial
    • Mosquito-Borne
    • Tick-Borne
    • Animal-Borne
    • Water/Fecal Transmission
    • and Other Diseases
  • 2022 Kalorama Market Estimates for:
    • Tuberculosis
    • Malaria
    • Lyme
    • Dengue
    • Other Emerging Diseases
    • Further Market Breakout for Mosquito-Borne and Tick-Borne Diseases
  • Diseases Identified by Major Health Agencies and Governments
  • The Need for Mosquito Control, Tick-Borne Disease Awareness, the Threat of Island Hopping Diseases and Other Trends
  • Diagnostic Products on the Market to Test for Emerging Infections

Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans.  Now with a global focus on testing, Kalorama’s update on all of the other diseases that could spread widely seems relevant.  It’s not to say that every disease will be like the COVID-19 pandemic – not all will be respiratory threats that can spread quickly.  Some pathogens spread through contact or insect vector, slower but often steadier pattern.  Vector-based tests such as Zika and malaria remain worrying and new diseases through that transmission method are troubling.  And non-respiratory diseases such as Ebola can still spread quickly person to person if not tested for and treated quickly.

Fortunately, the IVD industry is ready and companies have capacity to identify antigen targets and viral or bacterial RNA to be able to build high-sensitivity diagnostic products and produce tests at an ever-increasing rate.  This report covers their efforts with existing emerging diseases.

Table of Contents

Chapter 1: Executive Summary

Size and Growth of the Market

  • Figure 1-1: IVD Market for Emerging Diseases, 2021-2026
  • Figure 1-2: Market by Major Disease (TB, Malaria, Lyme, Dengue, All Other Emerging Diseases)

Monkey Pox Virus

 

Chapter 2: Discussion: The State of Emerging Infectious Diseases

  • Table 2-1: World Health Organization (WHO) Neglected Tropical Diseases

Mosquito Borne Illnesses

Controlling Mosquitos: Key to Disease Prevention

Malaria

Chikungunya

Diagnostics

Yellow Fever

Dengue

West Nile Virus

Zika

  • Table 2-2: Public Library of Science (PLOS) Major Neglected Tropical Diseases

Infections of High Concern

Tuberculosis

Chagas

Lyme Disease

Marburg virus

Rift Valley Fever

Ebola

Ross River Virus

CCHF

Nipah

Lassa Fever

Possibly Concerning Infections

Saint Louis Encephalitis

MERS

SARS

Variegated Squirrel Bornavirus

Killer Cold/ Adenoviridae 14

Heartland Virus

“Disease X”

 

Chapter 3: Viruses

  • Table 3-1: Highest Incidence Emerging Viruses (All Vectors)
  • Table 3-2: Viral Hemorrhagic Fevers (VHFs)
  • Table 3-3: Emerging and Neglected Viruses by Family and Region
  • Table 3-4: Emerging and Neglected Viruses by Vector and Family
  • Table 3-4a: Emerging and Neglected Viruses by Vector and Family [continued]
  • Table 3-5: Emerging and Neglected Viruses by Vector and Family (% by vector)
  • Table 3-5a: Emerging and Neglected Viruses by Vector and Family (% by vector)
  • Table 3-6a: Emerging and Neglected Viruses by Vector and Family (% by family) [cont.]
  • Table 3-6b: Emerging and Neglected Viruses by Vector and Family (% by family)

 

Chapter 4: Bacterial Infections

  • Table 4-1: Emerging Bacterial Infectious Diseases
  • Table 4-2a: Bacteria by Vector
  • Table 4-2b: Bacteria by Vector

 

Chapter 5: Mosquito-Borne Diseases

  • Table 5-1: Mosquito-borne Viruses
  • Table 5-2: Mosquito-borne Parasites

 

Chapter 6: Tick-Borne Disease

  • Table 6-1: Tick-borne Viruses
  • Table 6-2: Tick-borne Non-virus Pathogens

 

Chapter 7: Other Emerging Infectious Diseases

Water/Fecal Transmitted Pathogens

  • Table 7-1: Water/Fecal Transmitted Pathogens (overall)

Other Animal-Borne Viruses

  • Table 7-2: Rodent-borne Viruses
  • Table 7-3: Bat-borne Viruses
  • Table 7-4: Other Vertebrate-borne Viruses

Human to Human Virus

  • Table 7-5: Human-human Transmissible Viruses
  • Table 7-6: Human-human Transmissible Non-virus Pathogens

Livestock, Pet, Meat-Borne Pathogens

  • Table 7-8: Livestock / Pet/ Meat-borne Pathogens (overall)

Other Insect Pathogens (Non-Mosquito, Non Tick)

  • Table 7-9: Sandfly-borne Pathogens (overall)
  • Table 7-10: Fly-borne Pathogens (overall)
  • Table 7-11: Midge-borne Pathogens (overall)
  • Table 7-12: Other-Insect-borne Pathogens/ Diseases (overall)

Airborne Pathogens

  • Table 7-13: Airborne Spore Pathogens

Pathogens with Undefined Vectors

  • Table 7-14: Pathogens with Undefined Vectors

 

Chapter 8: Markets for Major Emerging Infectious Diseases

  • Figure 8-1: IVD Market Analysis for Emerging Infectious Diseases, 2021 -2026
  • Figure 8-2: IVD Market by Disease (Tuberculosis, Malaria, Lyme, Dengue Virus, Other Emerging)
  • Figure 8-3: Market %  by Type of Threat (Bacterial, Viral, Parasite)
  • Figure 8-4: Market %  by Type of Vector (Mosquito, Tick, Water/Fecal, Human, Other)
  • Figure 8-5: IVD Market, Mosquito-Based Disease by Type of Vector (Malaria, Dengue, Chikungunya, Zika, Other)
  • Figure 8-6: IVD Market, Tick-Based Disease by Type of Vector (Lyme, West Nile, Babesia, Other)

 

Chapter 9: Products on the Market

  • Table 9-1: Emerging/Neglected Diseases Diagnostic, Screening, & RUO Test Products
  • Table 9-1: Emerging/Neglected Diseases Diagnostic, Screening, & RUO Test Products
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Benchmarking for 2022: Understanding the IVD Customer ExperienceSingle Cell Analysis Survey
Scroll to top